University of Iowa
Iowa City, Iowa, 52242-3521, United States
Location status: Recruiting
NCT Number: NCT07715669
Preeclampsia is a condition in pregnancy where a woman develops high blood pressure and other complications. Women who develop preeclampsia are 4 times more likely to have heart disease later in life. They are also more likely to have depression after pregnancy. Why they are more likely to develop these conditions is not known. It may be because their blood vessels were damaged during pregnancy. Changes in blood vessel health can predict heart disease. These changes have been recorded after pregnancy in women who had preeclampsia. These changes have also been recorded in women who have depression. In the previous phase of this award, we found that women who had preeclampsia in pregnancy had changes in blood vessel health after pregnancy. We also found that if these women were taking a medicine to treat depression, their blood vessel health was normal. This could mean that treatment for depression can also increase blood vessel health in women who had preeclampsia. In this project we will study how changes in blood vessel health are related to preeclampsia and depression in women who have had both. We will also study how medicine to treat depression can improve blood vessel health after preeclampsia. We will do this by measuring how blood vessels work in women who have had preeclampsia compared to women who did not, and in women who have depression and women who do not. This will tell us more about why risk for depression and heart disease is higher in women who have had preeclampsia. It will also help us understand if medicine for depression can reduce cardiovascular disease risk after preeclampsia.
Interested in participating?
Request Info18 year–45 year
Female
Interventional
Early Phase 1
Iowa City, Iowa, 52242-3521, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
18-24 years old, 12 weeks - 5 years post pregnancy one of the following:
Exclusion criteria
history of cardiovascular, metabolic, and/or skin diseases current or history of tobacco/nicotine/ e-cigarette use history of gestational diabetes current antihypertensive or cholesterol-lowering medication currently pregnant allergy to materials used during the experiment (e.g. latex), known allergy to study drugs currently using SSRI medications
Localized delivery of paroxetine HCl to the cutaneous microvasculature via intradermal microdialysis.
Localized delivery of ascorbic acid to the cutaneous microvasculature via intradermal microdialysis.
Time frame: at the study visit, an average of 4 hours
Cutaneous vascular conductance responses to local heating over a microdialysis fiber receiving treatments compared to lactated Ringer's solution (control).
Time frame: at the study visit, an average of 4 hours
Difference in cutaneous vascular conductance between local heating plateau and post-L-NAME plateau within each treated microdialysis site compared to lactated Ringer's (control).
Contact information is provided by the study sponsor or research team.
Anna Stanhewicz, PhD
Other
Role of Antidepressant Therapy to Improve Vascular Function After Preeclampsia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728656
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Osijek, Croatia
View Trial DetailsNCT07218237
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Providence, Rhode Island, United States
View Trial DetailsNCT04154332
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Birmingham, Alabama, United States
View Trial DetailsNCT06033131
Birth Weight, Body Weight
Helsinki, Finland
View Trial Details